Page 14 - Robert Kramer News Today

The U.S. government canceled a contract related to pandemic preparation.

The federal government has canceled a multimillion dollar deal with a vaccine manufacturer that was found to have produced millions of contaminated Johnson & Johnson vaccine doses this spring.

The federal government's contract with vaccine manufacturer Emergent BioSolutions has been canceled—and as with the end of many troubled relationships, there's disagreement...

During its third quarter earnings presentation, Emergent BioSolutions revealed that its contract to produce COVID-19 vaccines for the U.S. government has been terminated. Since April, the Maryland-based company has been steeped in controversy for ruining millions of COVID-19 vaccine doses because of cross-contamination as it produced shots for AstraZeneca and Johnson & Johnson from its troubled facility in Baltimore.

BOMB Magazine has been publishing conversations between artists of all disciplines since 1981.

An analysis by OPB of hacked data uncovers police officers, sheriff’s deputies and military in Oregon who had joined the far right militia group since 2009.

To quote Kramer, “this is a game changer for a lot of people.”

FDA allows troubled Baltimore COVID-19 vaccine factory to resume operations By Linda A. Johnson Why CDC recommends wearing masks indoors even if fully vaccinated The CDC updated guidance on masks, saying on July 27, 2021, that people in areas of high COVID-19 transmission should wear them indoors regardless of vaccination status. BALTIMORE (AP) - The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of C...

ADVERTISEMENT FDA allows Emergent factory to resume vaccine work by LINDA A. JOHNSON THE ASSOCIATED PRESS | Today at 4:06 a.m. FILE - In this April 8, 2021 file photo, the Johnson & Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thur...

Jul 29 2021, 9:04 PM July 29 2021, 7:19 PM July 29 2021, 9:04 PM (Bloomberg) -- The U.S. Food and Drug Administration cleared Johnson & Johnson’s Covid-19 vaccine manufacturer Emergent BioSolutions Inc. to resume production of the shot after a series of mishaps that led it to halt manufacturing. (Bloomberg) -- The U.S. Food and Drug Administration cleared Johnson & Johnson’s Covid-19 vaccine manufacturer Emergent BioSolutions Inc. to resume production of the shot after a series of mis...